SolicitationPosted Jan 14, 2026·Responses due Jan 26, 2026

6506--VAPAHCS Human Blood and Blood Related Products

Veterans Affairs · 261-NETWORK CONTRACT OFFICE 21 (36C261)

Stage
Open solicitation
NAICS
621991
Value
Not stated
Solicitation
36C26126Q0165
Set-aside
None stated
PSC
6506
Place
Not stated
Contact
Tawnya S Krommenhoek (tawnya.krommenhoek@va.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 36C26126Q0165 in this department, oldest first.

Early notice
  • Nov 14, 2025
    Sources Sought
    Open
  • Dec 18, 2025
    Pre-solicitation
    Open
Solicitation
  • Dec 18, 2025
    Solicitation
    Open
  • Jan 14, 2026 · this notice
    Solicitation
Award
  • Mar 2, 2026
    Award Notice
    THE LELAND STANFORD JUNIOR UNIVERSITY STANFORD 94305 · $6.3M
    Open

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Decide bid or no bid before the response deadline.
  • Look at the past winners for likely competitors and teaming partners.
  • Follow the opportunity to hear about amendments and the award.

What the notice says

VAPAHCS Human Blood and Blood Related Products Questions and Answers 36C26126Q0165 QUESTION: I noticed that the volumes suggest the Palo Alto VA uses 1400 Autologous RBCs. Can you help me understand why? � Typically, we do not see this many autologous units given at any of the hospitals we currently service, so I m curious to understand the reasoning or patient population(s) that are requiring autologous RBCs. ANSWER: 1400 is a typo. On our last contract we indicated 15 units- see chart below. We rarely get autologous RBCs. We had 2 between 8/2024 and 8/2025. The 1400 has been corrected Please… (show all)

see updated Price List (36C26126DXXXX_PRICE LIST_V2). QUESTION: There is a small, steady number of HLA-specific products and testing. � Can you share with me the types of patient populations that are being treated and need this type of testing (i.e, Transplant, oncology, etc.)? ANSWER: The majority of these orders come from the Transplant/Cardiology Department. QUESTION: The response date is January 19th, 2026. However, given the extended holiday period and many key individuals out of the office for various periods, it is unlikely we will meet the submission date, particularly since we will likely need to redline the solicitation to have agreed-upon terms for the award. � If the start is not until June, we ask that the submission date occur at the beginning of March. ANSWER: The RFQ Close Date has been extended to January 26, 2026. QUESTION: Just so I am clear, the request is for us to complete the 36C26126DXXXX_PRICE LIST.xlsx spreadsheet with our pricing and part numbers for the five ordering periods and return that and the signed RFQ back to you by January 16, 2026. I do not need to do this through the SAM.gov site. ANSWER: Correct. This is a new solicitation, please follow the instructions in the solicitation document. QUESTION: Would there be an opportunity for us to add new products and remove products/services we no longer perform? There would be no volume commitment. It is just a way for us to have all the products and services we offer as part of the agreement. ANSWER: Yes QUESTION: If so, can I adjust the spreadsheet? ANSWER: Yes, you are free to adjust the spreadsheet. As a courtesy, please just highlight the changes you make to it.

Who won similar work

7 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Veterans Affairs), same product/service code (PSC) 6506.

Single-winner award sizes (7): middle half $541K to $1.7M, median $1.3M; range $100K to $5.2M.

WinnerAwardsValueLast
VITALANT Scottsdale AZ 85258 USA2$7.2MJul 28, 2026
AMERICAN NATIONAL RED CROSS, THE WASHINGTON 200061$1.4MOct 2, 2026
CENTRAL PENNSYLVANIA BLOOD BANK HUMMELSTOWN 170361$1.3MMar 2, 2026
GREATER METROPOLITAN COMMUNITY BLOOD SERVICE, INC.1$632KOct 1, 2026
CENTRAL CALIFORNIA BLOOD CENTER Fresno CA 93722 USA1$450KMay 19, 2026
AMERICAN NATIONAL RED CROSS, THE Charlotte NC 28273 USA1$100KAug 25, 2025

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Latest awards

Competitive landscape

For the 6 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
  • 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 25 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.